GRACELL BIOTECHNOLOGIES INC

CUSIP: 38406L103 Class: ADR

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 192,465 Value ($000) $1,932 Avg Close — Range —
Q3 2023
Shares 119,489 Value ($000) $344 Avg Close — Range —
Q2 2023
Shares 225,628 Value ($000) $860 Avg Close — Range —
Q1 2022
Shares 38,752 Value ($000) $89 Avg Close — Range —
Q4 2021
Shares 87,328 Value ($000) $528 Avg Close — Range —
Q3 2021
Shares 70,306 Value ($000) $975 Avg Close — Range —
Q2 2021
Shares 75,034 Value ($000) $976 Avg Close — Range —
Q1 2021
Shares 100,433 Value ($000) $1,547 Avg Close — Range —